{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:28:48Z","timestamp":1772231328549,"version":"3.50.1"},"reference-count":15,"publisher":"BMJ","issue":"e3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2022,8,24]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Emerging evidence suggests that methadone has a specific role in the management of treatment resistant cancer-related pain.<\/jats:p><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate the utilisation pattern, safety and efficacy of methadone prescribed as an analgesic for the management of complex cancer-related pain in an acute hospital inpatient setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective longitudinal observational study of patients prescribed methadone as an analgesic between April 2020 and July 2021 was performed.<\/jats:p><jats:p>Changes in coprescribed baseline opioid, use of breakthrough opioid analgesic, patient rated pain scores and adverse side effects were analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>16 patients with complex cancer-related treatment resistant pain who were prescribed methadone were included in the study. Of the 16 patients, 14 patients had metastatic disease. Pain was classified in 14 patients as mixed nociceptive-neuropathic and in 2 patients as neuropathic. 13 patients were coprescribed methadone with a pre-established opioid. Methadone was associated with a statistically significant decrease in both opioid breakthrough analgesic by 61%\u00b128% (p&lt;0.001), and coprescribed opioid by 17%\u00b112% (p=0.015). Patient rated pain scores were also significantly decreased (p&lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Methadone appears to have a specific role in the management of complex cancer pain, neuropathic pain, opioid-tolerance and opioid-induced hyperalgesia, which may be attributable to N-methyl-D-aspartate receptor antagonism.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2022-003586","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T17:20:25Z","timestamp":1663176025000},"page":"e839-e842","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Methadone prescribed as an analgesic by a specialist palliative medicine team in an acute hospital inpatient setting: retrospective study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5177-1775","authenticated-orcid":false,"given":"Jennifer","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3152-040X","authenticated-orcid":false,"given":"Dympna","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk J","family":"Levins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahrukh","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"2024121022580601000_13.e3.e839.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(00)00228-1"},{"key":"2024121022580601000_13.e3.e839.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(02)00016-3"},{"key":"2024121022580601000_13.e3.e839.3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/2049463714545136","article-title":"Cancer pain physiology","volume":"8","author":"Falk","year":"2014","journal-title":"Br J Pain"},{"key":"2024121022580601000_13.e3.e839.4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1526-4637.2010.00840.x","article-title":"Cancer pain: Part 1: pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British pain Society endorsed by the UK association of palliative medicine and the Royal College of general practitioners","volume":"11","author":"Raphael","year":"2010","journal-title":"Pain Med"},{"key":"2024121022580601000_13.e3.e839.5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","article-title":"Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper","volume":"57","author":"McPherson","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2024121022580601000_13.e3.e839.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2018-001695"},{"key":"2024121022580601000_13.e3.e839.7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpainsymman.2011.06.005","article-title":"Use of methadone as a coanalgesic","volume":"42","author":"McKenna","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"2024121022580601000_13.e3.e839.8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/jpm.2019.0253","article-title":"The use of low-dose methadone as add-on to regular opioid therapy in cancer-related pain at end of life: a national Swedish survey in specialized palliative care","volume":"23","author":"F\u00fcrst","year":"2020","journal-title":"J Palliat Med"},{"key":"2024121022580601000_13.e3.e839.9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/082585971002600306","article-title":"The Effectiveness and Adverse Effects profile of \u201cBurst\u201d Ketamine in Refractory Cancer Pain: The Vcog Pm 1-00 Study","volume":"26","author":"Jackson","year":"2010","journal-title":"J Palliat Care"},{"key":"2024121022580601000_13.e3.e839.10","unstructured":"Waldron D , Grummell M , Daniels F . A retrospective review to test the hypothesis that \u201copioid toxicity\u201d, developing in an otherwise stable patient heralds imminent sepsis. Palliative Medicine 2008;22."},{"key":"2024121022580601000_13.e3.e839.11","article-title":"Methadone for cancer pain","volume":"2","author":"Nicholson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2024121022580601000_13.e3.e839.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3064"},{"key":"2024121022580601000_13.e3.e839.13","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1200\/JCO.1999.17.11.3603","article-title":"Quality-Of-Life measurement in advanced cancer: assessing the individual","volume":"17","author":"Waldron","year":"1999","journal-title":"J Clin Oncol"},{"key":"2024121022580601000_13.e3.e839.14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0149-2918(02)85111-6","article-title":"Response shift in individualized quality of life in patients with advanced prostate cancer","volume":"24","author":"Rees","year":"2002","journal-title":"Clin Ther"},{"key":"2024121022580601000_13.e3.e839.15","unstructured":"Shockney . 2020 top stories in metastatic breast cancer: chemotherapy at the end of Life\u2014We can do better by our patients. Oncology 2020."}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2022-003586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T07:17:23Z","timestamp":1733901443000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2022-003586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":15,"journal-issue":{"issue":"e3","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/spcare-2022-003586"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2022-003586","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}